The text of this site is referenced to these sources.

  1. Aso T, et al. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women J Womens Health 2012;21(1):92-100. PMID: 21992596.
  2. Atkinson C, et al. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005;230;155-170. PMID: 15734719.
  3. Atkinson C, et al. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Am J Clin Nutr 2008;87:679-687. PMID: 18326607.
  4. Christian MS, et al. Dossier in support of the Generally Recognized as Safe (GRAS) status of SE5-OH as a food ingredient. Burdock Group Consultants. September 2008.
  5. Ishiwata N, et al. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause 2009;16:141-148. PMID: 19131846.
  6. Setchell KD, et al. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr 2009;139:2037–43. PMID 19776178.
  7. Setchell KD, et al. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006;136:2188-93. PMID: 16857839.
  8. Setchell KD, et al. The clinical importance of the metabolite equol — a clue to the effectiveness of soy and its isoflavones. J Nutr 2002;should be 132: 3577-84. PMID 12468591.
  9. Uchiyama S, et al. The cross-sectional study of the relationship between soy isoflavones, equol and the menopausal symptoms in Japanese women. J Jpn Menopause Soc 2007;15:28-37.
  10. Watanabe S, et al. Pharmacokinetics of an equol supplement in humans. Anti Aging Med 2007;4:57-62.
  11. Atkinson C, et al. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 2005;230:155–70. PMID: 15734719.
  12. Setchell KD, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005:81(5):1072–9. PMID: 15883431.
  13. Setchell KD, et al. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40:569–78. PMID: 6383008.
  14. Jou HJ, et al. Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. Int J Gynaecol Obstet 2008;102:44–9. PMID: 18395723.
  15. Setchell KR, et al. Equol: History, Chemistry, and Formation. J. Nutr 2010;140(7): 1355S-1362S. PMID: 20519412.
  16. Aso T, Equol Improves Menopausal Symptoms in Japanese Women. J. Nutr 2010; 140(7):1386S-1389S. PMID: 20484552.
  17. Jenks BH, et al. A Pilot Study on The Effects of S-equol Compared to Soy Isoflavones on Menopausal Hot Flash Frequency and Other Menopausal Symptoms. J Womens Health 2012;21(6):674-82. PMID: 22409590.
  18. Jenks BH, et al. Endocrine and Safety Assessment Pre- and Post-Ingestion of Natural S-equol for 12 Weeks in Healthy Japanese Adult Males. Experimental Biology 2010, Poster A76.
  19. Usui T, et al. The effect of a natural S-equol supplement on metabolic parameters in overweight adult Japanese males and females in equol- and non equol-producers. Women’s Health Congress 2012, Poster P41